NBIX logo

Neurocrine Biosciences, Inc. (NBIX)

Profile

Full Name

Neurocrine Biosciences, Inc.

Ticker

NASDAQ: NBIX

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

May 23, 1996

Indexes

Not included

Website

http://www.neurocrine.com

Employees

1800

Key Details

Price

$132.14(+0.38%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.36B(+24.81% YoY)

Annual EPS

$3.29(+33.20% YoY)

PE ratio

44.79

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $132.14
    NBIX price is $132.14

    30-Day Relative Volume

    1.52
    NBIX 30-day relative volume is 1.52

    Price Performance

    Price Most recent change

    +0.38%
    NBIX price was up +0.38% on Jul 25, 2025

    Price YTD change

    -3.19%
    NBIX price is down -3.19% since January 1st

    Price 1-year change

    -9.56%
    NBIX price is down -9.56% year-on-year

    Price 3-year change

    +38.73%
    NBIX price is up +38.73% over the past 3 years

    Price Range

    Price All-time high

    $157.98
    NBIX price is currently -16.36% below its historical high of $157.98

    Price 3-year low

    $84.23
    NBIX price is currently +56.88% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $13.08B
    NBIX market capitalization is $13.08 billion

    Market cap 3-year change

    +43.61%
    NBIX market capitalization is up +43.61% over the past 3 years

    Market cap All-time high

    $15.65B
    NBIX market capitalization is currently -16.45% below its historical high of $15.65 billion

    Market cap sector rank

    93.65%
    NBIX market capitalization is higher than 93.65% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.92%
    NBIX shares outstanding is down -1.92% year-on-year

    Shares Outstanding 3-Year Change

    +3.52%
    NBIX shares outstanding is up +3.52% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.84
    NBIX beta is 0.84

    200-day SMA

    $122.73
    NBIX price is currently +7.67% above its 200-day simple moving average

    50-day SMA

    $126.85
    NBIX price is currently +4.17% above its 50-day simple moving average

    RSI

    55.90
    NBIX 14-day relative strength index is 55.90

    Volume

    1.52
    NBIX 30-day relative volume is 1.52

    ATR

    $3.00
    NBIX average true range is $3.00

    10-day Historical Volatility

    22.92%
    NBIX 10-day historical volatility is 22.92%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.36B
    NBIX annual revenue is $2.36 billion

    Revenue Analysts estimate

    $2.69B
    NBIX annual revenue is currently -12.30% lower than the consensus analysts' forecast

    Revenue 1-year change

    +24.81%
    NBIX annual revenue is up +24.81% year-on-year

    Revenue Sector rank

    86.06%
    NBIX annual revenue is higher than 86.06% of companies in Healthcare sector

    EPS

    EPS

    $3.29
    NBIX annual earnings per share is $3.29

    EPS Analysts estimate

    $6.07
    NBIX annual earnings per share is currently -45.77% lower than the consensus analysts' forecast

    EPS 1-year change

    +33.2%
    NBIX annual earnings per share is up +33.2% year-on-year

    EPS Sector rank

    93.86%
    NBIX annual earnings per share is higher than 93.86% of companies in Healthcare sector

    Profit

    Gross profit

    $2.32B
    NBIX annual gross profit is $2.32 billion

    Gross margin

    98.56%
    NBIX annual gross profit margin is 98.56%

    Operating profit

    $583.00M
    NBIX annual operating income is $583.00 million

    Operating margin

    24.75%
    NBIX annual operating profit margin is 24.75%

    Net income

    $341.30M
    NBIX annual net profit is $341.30 million

    Net margin

    14.49%
    NBIX annual net profit margin is 14.49%

    Expenses

    Total expenses

    $1.77B
    NBIX annual total expenses is $1.77 billion

    Operating expenses

    $1.74B
    NBIX annual total operating expenses is $1.74 billion

    Cost of goods sold

    $34.00M
    NBIX annual cost of goods sold is $34.00 million

    Selling, general & administrative expenses

    $1.01B
    NBIX annual SGA is $1.01 billion

    Depreciation and amortization

    $27.10M
    NBIX annual depreciation & amortization is $27.10 million

    Interest expense

    $126.60M
    NBIX annual interest expense is $126.60 million

    Income tax

    $144.70M
    NBIX annual income tax is $144.70 million

    EBIT & EBITDA

    EBIT

    $583.00M
    NBIX annual earnings before interest & taxes is $583.00 million

    EBITDA

    $583.00M
    NBIX annual EBITDA is $583.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.72B
    NBIX annual total assets is $3.72 billion

    Non current assets

    $1.99B
    NBIX annual long term assets is $1.99 billion

    Current assets

    $1.72B
    NBIX annual total current assets is $1.72 billion

    Cash and cash equivalents

    $233.00M
    NBIX annual cash & cash equivalents is $233.00 million

    Accounts receivable

    $479.10M
    NBIX annual accounts receivable is $479.10 million

    Inventory

    $57.40M
    NBIX annual inventory is $57.40 million

    Liabilities

    Total liabilities

    $1.13B
    NBIX annual total liabilities is $1.13 billion

    Long term liabilities

    $621.30M
    NBIX annual total long term liabilities is $621.30 million

    Current liabilities

    $507.70M
    NBIX annual total current liabilities is $507.70 million

    Accounts payable

    $110.00M
    NBIX annual accounts payable is $110.00 million

    Debt

    Total debt

    $455.10M
    NBIX annual total debt is $455.10 million

    Total debt 1-year change

    +6.23%
    NBIX annual total debt is up +6.23% year-on-year

    Long term debt

    $455.10M
    NBIX annual long term debt is $455.10 million

    Short term debt

    -
    NBIX annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $2.59B
    NBIX annual stockholders equity is $2.59 billion

    Book value

    $2.59B
    NBIX annual book value is $2.59 billion

    Retained earnings

    $29.20M
    NBIX annual retained earnings is $29.20 million

    Working capital

    $1.22B
    NBIX annual working capital is $1.22 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $595.40M
    NBIX annual cash flow from operations is $595.40 million

    Cash from operations 1-year change

    +52.71%
    NBIX annual cash flow from operations is up +52.71% year-on-year

    Cash from investing

    -$126.80M
    NBIX annual cash flow from investing activities is -$126.80 million

    Cash from investing 1-year change

    +72.85%
    NBIX annual cash flow from investing activities is up +72.85% year-on-year

    Cash from financing

    -$486.70M
    NBIX annual cash flow from financing activities is -$486.70 million

    Cash from financing 1-year change

    -845.33%
    NBIX annual cash flow from financing activities is down -845.33% year-on-year

    CAPEX

    CAPEX

    $38.20M
    NBIX annual capital expenditures is $38.20 million

    CAPEX 1-year change

    +34.98%
    NBIX annual capital expenditures is up +34.98% year-on-year

    Free Cash Flow

    Free cash flow

    $557.20M
    NBIX annual free cash flow is $557.20 million

    Free cash flow 1-year change

    +54.09%
    NBIX annual free cash flow is up +54.09% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    98.56%
    NBIX annual gross profit margin is 98.56%

    Operating margin

    24.75%
    NBIX annual operating profit margin is 24.75%

    Net margin

    14.49%
    NBIX annual net profit margin is 14.49%

    ROA & ROE

    ROA

    9.79%
    NBIX annual return on assets is 9.79%

    ROE

    14.16%
    NBIX annual return on equity is 14.16%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    44.79
    NBIX price to earnings ratio is 44.79

    PE ratio Sector rank

    76.42%
    NBIX price to earnings ratio is higher than 76.42% of companies in Healthcare sector

    PB Ratio

    PB ratio

    5.16
    NBIX price to book ratio is 5.16

    PB ratio Sector rank

    80.07%
    NBIX price to book ratio is higher than 80.07% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.42
    NBIX price to sales ratio is 5.42

    PS ratio Sector rank

    64.27%
    NBIX price to sales ratio is higher than 64.27% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $13.33B
    NBIX enterprise value is $13.33 billion

    Enterprise value Sector rank

    93.41%
    NBIX enterprise value is higher than 93.41% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    23.83
    NBIX EV/EBITDA is 23.83

    EV/EBITDA Sector rank

    92.96%
    NBIX EV/EBITDA is higher than 92.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.40
    NBIX annual current ratio is 3.40

    Quick ratio

    3.28
    NBIX annual quick ratio is 3.28

    Leverage

    Debt to equity

    0.00
    NBIX annual debt to equity ratio is 0.00

    Interest coverage ratio

    4.61
    NBIX annual interest coverage ratio is 4.61

    Risk & Stability

    Piotroski F-Score

    7
    NBIX piotroski f-score is 7

    Altman Z-Score

    8.50
    NBIX altman z-score is 8.50

    Analyst ratings

    Recent major analysts updates

    Jul 22, 25 Morgan Stanley
    Overweight
    Jul 21, 25 Truist Securities
    Buy
    Jul 10, 25 Goldman Sachs
    Buy
    Jul 9, 25 UBS
    Buy
    Jun 2, 25 RBC Capital
    Outperform
    May 6, 25 UBS
    Buy
    May 6, 25 RBC Capital
    Outperform
    May 6, 25 Piper Sandler
    Overweight
    May 6, 25 Needham
    Buy
    May 6, 25 Guggenheim
    Buy

    Institutional Ownership

    Screeners with NBIX included

    US stocks
    High Piotroski score stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Neurocrine Biosciences, Inc.?
    • Does Neurocrine Biosciences, Inc. pay dividends?
    • What sector is Neurocrine Biosciences, Inc. in?
    • What industry is Neurocrine Biosciences, Inc. in?
    • What country is Neurocrine Biosciences, Inc. based in?
    • When did Neurocrine Biosciences, Inc. go public?
    • Is Neurocrine Biosciences, Inc. in the S&P 500?
    • Is Neurocrine Biosciences, Inc. in the NASDAQ 100?
    • Is Neurocrine Biosciences, Inc. in the Dow Jones?
    • When was Neurocrine Biosciences, Inc.'s last earnings report?
    • When does Neurocrine Biosciences, Inc. report earnings?

    What is the ticker symbol for Neurocrine Biosciences, Inc.?

    The ticker symbol for Neurocrine Biosciences, Inc. is NASDAQ:NBIX

    Does Neurocrine Biosciences, Inc. pay dividends?

    No, Neurocrine Biosciences, Inc. does not pay dividends

    What sector is Neurocrine Biosciences, Inc. in?

    Neurocrine Biosciences, Inc. is in the Healthcare sector

    What industry is Neurocrine Biosciences, Inc. in?

    Neurocrine Biosciences, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Neurocrine Biosciences, Inc. based in?

    Neurocrine Biosciences, Inc. is headquartered in United States

    When did Neurocrine Biosciences, Inc. go public?

    Neurocrine Biosciences, Inc.'s initial public offering (IPO) was on May 23, 1996

    Is Neurocrine Biosciences, Inc. in the S&P 500?

    No, Neurocrine Biosciences, Inc. is not included in the S&P 500 index

    Is Neurocrine Biosciences, Inc. in the NASDAQ 100?

    No, Neurocrine Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Neurocrine Biosciences, Inc. in the Dow Jones?

    No, Neurocrine Biosciences, Inc. is not included in the Dow Jones index

    When was Neurocrine Biosciences, Inc.'s last earnings report?

    Neurocrine Biosciences, Inc.'s most recent earnings report was on May 5, 2025

    When does Neurocrine Biosciences, Inc. report earnings?

    The next expected earnings date for Neurocrine Biosciences, Inc. is August 1, 2025
    On this page